Development and Initial Validation of a New Stent Symptom Questionnaire for Short-Term Dwell Time: The Canadian Endourology Group Stent Symptom Score

PURPOSE: We sought to develop and validate the Canadian Endourology Group Stent Symptom Score (CEGSSS), a short and concise Ureteral Stent Symptom Questionnaire to assess the patient-reported impact of ureteral stents in patients with indwelling stents for < 2 weeks. MATERIALS AND METHODS: We used a rigorous 3-phase study design: phase 1: Prioritizing domains/items to be included in a minimal needs data set with the help of patient partners and experts. Phase 2: Pilot study of patients with ureteral stents evaluating the feasibility and acceptability of the CEGSSS. Phase 3: Multicentric, North American prospective study evaluating the validity and reliability of the CEGSSS. RESULTS: < .001). CONCLUSIONS: This 3-phase development, reliability, and validation study confirms the utility of a new ureteral stent symptoms questionnaire. The CEGSSS is a practical, user-friendly tool that is quicker to complete than the Ureteral Stent Symptom Questionnaire.